Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

17.03
+0.02000.12%
Post-market: 17.030.00000.00%16:10 EDT
Volume:332.38K
Turnover:5.66M
Market Cap:882.64M
PE:16.30
High:17.07
Open:17.02
Low:17.00
Close:17.01
52wk High:21.03
52wk Low:13.08
Shares:51.83M
Float Shares:25.78M
Volume Ratio:0.89
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.05
EPS(LYR):2.06
ROE:20.91%
ROA:1.33%
PB:3.05
PE(LYR):8.27

Loading ...

Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Sep 14, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Major Issues Report

8-K - Current report
Jul 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jul 06, 2020

Major Issues Report

8-K - Current report
Jun 25, 2020

Major Issues Report

8-K - Current report
Jun 23, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 22, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 11, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 10, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01